Annual Cash & Cash Equivalents
$121.14 M
-$79.88 M-39.74%
December 31, 2023
Summary
- As of February 7, 2025, SAVA annual cash & cash equivalents is $121.14 million, with the most recent change of -$79.88 million (-39.74%) on December 31, 2023.
- During the last 3 years, SAVA annual cash & cash equivalents has risen by +$27.63 million (+29.55%).
- SAVA annual cash & cash equivalents is now -48.11% below its all-time high of $233.44 million, reached on December 31, 2021.
Performance
SAVA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$148.98 M
-$58.31 M-28.13%
September 30, 2024
Summary
- As of February 7, 2025, SAVA quarterly cash and cash equivalents is $148.98 million, with the most recent change of -$58.31 million (-28.13%) on September 30, 2024.
- Over the past year, SAVA quarterly cash and cash equivalents has increased by +$6.63 million (+4.66%).
- SAVA quarterly cash and cash equivalents is now -47.21% below its all-time high of $282.19 million, reached on March 31, 2021.
Performance
SAVA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SAVA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.7% | +4.7% |
| 3 y3 years | +29.6% | +4.7% |
| 5 y5 years | +511.6% | +4.7% |
SAVA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.1% | at low | -36.2% | +23.0% |
| 5 y | 5-year | -48.1% | +424.8% | -47.2% | +545.5% |
| alltime | all time | -48.1% | +8684.3% | -47.2% | >+9999.0% |
Cassava Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $148.98 M(-28.1%) |
| Jun 2024 | - | $207.29 M(+66.9%) |
| Mar 2024 | - | $124.17 M(+2.5%) |
| Dec 2023 | $121.14 M(-39.7%) | $121.14 M(-14.9%) |
| Sep 2023 | - | $142.35 M(-15.5%) |
| Jun 2023 | - | $168.44 M(-10.2%) |
| Mar 2023 | - | $187.47 M(-6.7%) |
| Dec 2022 | $201.01 M(-13.9%) | $201.01 M(+15.1%) |
| Sep 2022 | - | $174.66 M(-11.4%) |
| Jun 2022 | - | $197.23 M(-5.9%) |
| Mar 2022 | - | $209.69 M(-10.2%) |
| Dec 2021 | $233.44 M(+149.6%) | $233.44 M(-3.3%) |
| Sep 2021 | - | $241.52 M(-13.2%) |
| Jun 2021 | - | $278.25 M(-1.4%) |
| Mar 2021 | - | $282.19 M(+201.8%) |
| Dec 2020 | $93.51 M(+305.1%) | $93.51 M(+288.4%) |
| Sep 2020 | - | $24.07 M(-4.7%) |
| Jun 2020 | - | $25.25 M(-1.4%) |
| Mar 2020 | - | $25.60 M(+10.9%) |
| Dec 2019 | $23.08 M(+16.5%) | $23.08 M(+29.6%) |
| Sep 2019 | - | $17.80 M(-3.9%) |
| Jun 2019 | - | $18.53 M(-3.1%) |
| Mar 2019 | - | $19.13 M(-3.4%) |
| Dec 2018 | $19.81 M(+89.0%) | $19.81 M(-3.1%) |
| Sep 2018 | - | $20.44 M(+112.8%) |
| Jun 2018 | - | $9.61 M(-10.5%) |
| Mar 2018 | - | $10.73 M(+2.4%) |
| Dec 2017 | $10.48 M(-36.9%) | $10.48 M(-12.1%) |
| Sep 2017 | - | $11.92 M(-15.3%) |
| Jun 2017 | - | $14.07 M(-18.5%) |
| Mar 2017 | - | $17.26 M(+3.9%) |
| Dec 2016 | $16.61 M(-46.9%) | $16.61 M(-21.7%) |
| Sep 2016 | - | $21.21 M(-13.9%) |
| Jun 2016 | - | $24.63 M(-7.5%) |
| Mar 2016 | - | $26.61 M(-15.0%) |
| Dec 2015 | $31.30 M(-22.9%) | $31.30 M(-7.9%) |
| Sep 2015 | - | $33.99 M(-6.5%) |
| Jun 2015 | - | $36.35 M(-2.4%) |
| Mar 2015 | - | $37.25 M(-8.2%) |
| Dec 2014 | $40.59 M(-16.5%) | $40.59 M(-3.5%) |
| Sep 2014 | - | $42.05 M(-5.7%) |
| Jun 2014 | - | $44.58 M(-2.8%) |
| Mar 2014 | - | $45.85 M(-5.6%) |
| Dec 2013 | $48.59 M(-1.6%) | $48.59 M(-2.3%) |
| Sep 2013 | - | $49.73 M(-3.5%) |
| Jun 2013 | - | $51.55 M(-0.1%) |
| Mar 2013 | - | $51.59 M(+4.5%) |
| Dec 2012 | $49.35 M | $49.35 M(-44.1%) |
| Sep 2012 | - | $88.24 M(+11.7%) |
| Jun 2012 | - | $79.02 M(+7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $73.78 M(+0.9%) |
| Dec 2011 | $73.14 M(+1424.5%) | $73.14 M(+2.0%) |
| Sep 2011 | - | $71.71 M(+14.1%) |
| Jun 2011 | - | $62.83 M(+14.5%) |
| Mar 2011 | - | $54.89 M(+1044.1%) |
| Dec 2010 | $4.80 M(-86.6%) | $4.80 M(-95.5%) |
| Sep 2010 | - | $106.29 M(+59.2%) |
| Jun 2010 | - | $66.77 M(+31.8%) |
| Mar 2010 | - | $50.66 M(+41.5%) |
| Dec 2009 | $35.79 M(-76.6%) | $35.79 M(+22.7%) |
| Sep 2009 | - | $29.17 M(-79.9%) |
| Jun 2009 | - | $145.20 M(-16.0%) |
| Mar 2009 | - | $172.79 M(+12.8%) |
| Dec 2008 | $153.16 M(+76.9%) | $153.16 M(+6.4%) |
| Sep 2008 | - | $143.95 M(+14.8%) |
| Jun 2008 | - | $125.42 M(-4.1%) |
| Mar 2008 | - | $130.81 M(+51.1%) |
| Dec 2007 | $86.57 M(+428.3%) | $86.57 M(+112.1%) |
| Sep 2007 | - | $40.81 M(-17.0%) |
| Jun 2007 | - | $49.19 M(-20.4%) |
| Mar 2007 | - | $61.82 M(+277.2%) |
| Dec 2006 | $16.39 M(-82.9%) | $16.39 M(-48.1%) |
| Sep 2006 | - | $31.56 M(-38.3%) |
| Jun 2006 | - | $51.11 M(-24.6%) |
| Mar 2006 | - | $67.83 M(-29.1%) |
| Dec 2005 | $95.65 M(+6836.3%) | $95.65 M(+6631.2%) |
| Sep 2005 | - | $1.42 M(-43.4%) |
| Jun 2005 | - | $2.51 M(+2247.7%) |
| Mar 2005 | - | $107.00 K(-92.2%) |
| Dec 2004 | $1.38 M(-88.5%) | $1.38 M(-21.2%) |
| Sep 2004 | - | $1.75 M(-44.8%) |
| Jun 2004 | - | $3.17 M(-55.8%) |
| Mar 2004 | - | $7.18 M(-40.3%) |
| Dec 2003 | $12.03 M(-76.0%) | $12.03 M(-74.4%) |
| Sep 2003 | - | $46.90 M(+10.2%) |
| Jun 2003 | - | $42.55 M(-6.8%) |
| Mar 2003 | - | $45.66 M(-8.8%) |
| Dec 2002 | $50.09 M(-23.3%) | $50.09 M(-7.1%) |
| Sep 2002 | - | $53.89 M(-6.8%) |
| Jun 2002 | - | $57.81 M(-5.8%) |
| Mar 2002 | - | $61.36 M(-6.0%) |
| Dec 2001 | $65.27 M(-17.3%) | $65.27 M(-4.6%) |
| Sep 2001 | - | $68.44 M(-4.5%) |
| Jun 2001 | - | $71.64 M(-5.7%) |
| Mar 2001 | - | $75.95 M(-3.8%) |
| Dec 2000 | $78.93 M(+745.1%) | $78.93 M(-3.7%) |
| Sep 2000 | - | $82.00 M(+309.6%) |
| Jun 2000 | - | $20.02 M(-9.7%) |
| Mar 2000 | - | $22.18 M |
| Dec 1999 | $9.34 M | - |
FAQ
- What is Cassava Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cassava Sciences?
- What is Cassava Sciences annual cash & cash equivalents year-on-year change?
- What is Cassava Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cassava Sciences?
- What is Cassava Sciences quarterly cash and cash equivalents year-on-year change?
What is Cassava Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of SAVA is $121.14 M
What is the all time high annual cash & cash equivalents for Cassava Sciences?
Cassava Sciences all-time high annual cash & cash equivalents is $233.44 M
What is Cassava Sciences annual cash & cash equivalents year-on-year change?
Over the past year, SAVA annual cash & cash equivalents has changed by -$79.88 M (-39.74%)
What is Cassava Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SAVA is $148.98 M
What is the all time high quarterly cash and cash equivalents for Cassava Sciences?
Cassava Sciences all-time high quarterly cash and cash equivalents is $282.19 M
What is Cassava Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, SAVA quarterly cash and cash equivalents has changed by +$6.63 M (+4.66%)